Iatrogenic Botulism Following Unregulated Cosmetic Botulinum Toxin Injection

We report the case of a 35-year-old woman who developed progressive neuromuscular weakness, bulbar symptoms, and dysphagia following administration of unlicensed cosmetic botulinum toxin at home by a non-medical acquaintance. Her husband, who received injections from the same vial, was admitted to intensive care and required intubation. Our patient required close airway monitoring, antitoxin therapy, immunoglobulins, and multidisciplinary support, but did not require ventilatory support. She gradually improved and was discharged with ongoing outpatient neurology and speech therapy follow-up. This case highlights the dangers of unregulated access to botulinum toxin, the importance of early recognition of iatrogenic botulism, and the role of public health reporting in preventing further harm.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-09-29
DOI
https://doi.org/10.7759/cureus.93517
Citations
1
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Iatrogenic Botulism Following Unregulated Cosmetic Botulinum Toxin Injection

Abdul Basit
1 citations
Cureus
Botulinum Toxin and Related Neurological Disorders
1.39
article

Iatrogenic Botulism Following Unregulated Cosmetic Botulinum Toxin Injection

Abdul Basit
article en
1 citations

Abstract

We report the case of a 35-year-old woman who developed progressive neuromuscular weakness, bulbar symptoms, and dysphagia following administration of unlicensed cosmetic botulinum toxin at home by a non-medical acquaintance. Her husband, who received injections from the same vial, was admitted to intensive care and required intubation. Our patient required close airway monitoring, antitoxin therapy, immunoglobulins, and multidisciplinary support, but did not require ventilatory support. She gradually improved and was discharged with ongoing outpatient neurology and speech therapy follow-up. This case highlights the dangers of unregulated access to botulinum toxin, the importance of early recognition of iatrogenic botulism, and the role of public health reporting in preventing further harm.

CureusVol. 17(9)
Hinchingbrooke Hospital (GB)
Openalex Percentile: Top 15%
Botulinum Toxin and Related Neurological Disorders
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.